Foghorn Therapeutics Inc. (FHTX) has 20 已知的内部人和机构持有人记录. 最大持有人为 Flagship Pioneering Inc. 持有 1,814,914 股. 其他重要持有人包括 Flagship Pioneering, LLC 和 GOTTSCHALK ADRIAN.
过去12个月，内部人进行了 22 笔交易，涉及 FHTX 股票 — 18 笔买入 (价值为 $39.04M) 和 0 笔卖出 (价值为 RSU 奖励). 内部人买入超过卖出，可能表明对公司前景有信心.
FHTX 內部人持股
最大持股人
Flagship Pioneering Inc.
1,814,914 股
主要內部人持股
| # |
姓名 |
职位 |
持股数量 |
最近申报日期 |
相对规模 |
| 1 |
Flagship Pioneering Inc. |
10 Percent Owner |
1,814,914 |
2024-05-24 |
|
| 2 |
Flagship Pioneering, Llc |
10 Percent Owner |
1,117,734 |
2026-01-15 |
|
| 3 |
Gottschalk Adrian |
Chief Executive Officer |
1,075,000 |
2026-02-06 |
|
| 4 |
Maynard Ryan D |
Chief Financial Officer |
400,000 |
2026-02-24 |
|
| 5 |
Cardama Alfonso Quintas |
Chief Medical Officer |
300,000 |
2026-02-02 |
|
| 6 |
Bellon Steven F. |
Chief Scientific Officer |
300,000 |
2026-02-02 |
|
| 7 |
Lacascia Michael |
Chief Legal Officer |
295,000 |
2026-02-02 |
|
| 8 |
Costa Carlos |
Chief People Officer |
230,000 |
2026-02-02 |
|
| 9 |
Rivkin Anna |
Chief Business Officer |
165,000 |
2026-02-02 |
|
| 10 |
Humer Kristian |
Chief Financial Officer |
120,000 |
2025-01-24 |
|
| 11 |
Baselga Jose |
Director |
94,594 |
2020-10-22 |
|
| 12 |
Reine Allan |
Chief Financial Officer |
90,000 |
2023-01-30 |
|
| 13 |
Cavalie Fanny |
Chief Strategy/bus Ops Officer |
75,992 |
2024-03-12 |
|
| 14 |
Agresta Samuel |
Chief Medical Officer |
60,000 |
2023-01-30 |
|
| 15 |
Gallagher Neil |
Director |
50,000 |
2025-05-02 |
|
| 16 |
Duty Stuart |
Director |
50,000 |
2025-05-02 |
|
| 17 |
Decicco Carl |
Chief Scientific Officer |
34,273 |
2021-12-13 |
|
| 18 |
Smith Ian F |
Director |
25,000 |
2025-06-17 |
|
| 19 |
Cole Douglas G. |
Director |
25,000 |
2025-06-17 |
|
| 20 |
Parshall B Lynne |
Director |
25,000 |
2025-06-17 |
|
近期交易 (过去12个月)
| 日期 |
姓名 |
职位 |
类型 |
股数 |
股价 |
总价值 |
| 2026-02-23 |
Maynard Ryan D |
Chief Financial Officer |
限制性股票授予 (RSU) |
400,000 |
$5.75 |
$2.3M |
| 2026-02-23 |
Maynard Ryan D |
Officer |
未知 |
- |
- |
- |
| 2026-02-05 |
Gottschalk Adrian |
Chief Executive Officer |
限制性股票授予 (RSU) |
1,075,000 |
$5.23 |
$5.62M |
| 2026-01-30 |
Rivkin Anna |
Chief Business Officer |
限制性股票授予 (RSU) |
165,000 |
$5.71 |
$942.15K |
| 2026-01-30 |
Costa Carlos |
Chief People Officer |
限制性股票授予 (RSU) |
230,000 |
$5.71 |
$1.31M |
| 2026-01-30 |
Lacascia Michael |
Chief Legal Officer |
限制性股票授予 (RSU) |
295,000 |
$5.71 |
$1.68M |
| 2026-01-30 |
Bellon Steven F. |
Chief Scientific Officer |
限制性股票授予 (RSU) |
300,000 |
$5.71 |
$1.71M |
| 2026-01-30 |
Cardama Alfonso Quintas |
Chief Medical Officer |
限制性股票授予 (RSU) |
300,000 |
$5.71 |
$1.71M |
| 2026-01-13 |
Flagship Pioneering, Llc |
10 Percent Owner |
限制性股票授予 (RSU) |
1,117,734 |
$20.13 |
$22.5M |
| 2025-11-14 |
Humer Kristian |
Officer |
未知 |
- |
- |
- |
| 2025-06-17 |
Mendelsohn Michael |
Director |
限制性股票授予 (RSU) |
25,000 |
$4.79 |
$119.75K |
| 2025-06-17 |
Biller Scott |
Director |
限制性股票授予 (RSU) |
25,000 |
$4.79 |
$119.75K |
| 2025-06-17 |
Cole Douglas G. |
Director |
限制性股票授予 (RSU) |
25,000 |
$4.79 |
$119.75K |
| 2025-06-17 |
Lynch Thomas J. Jr. |
Director |
限制性股票授予 (RSU) |
25,000 |
$4.79 |
$119.75K |
| 2025-06-17 |
Smith Ian F |
Director |
限制性股票授予 (RSU) |
25,000 |
$4.79 |
$119.75K |
| 2025-06-17 |
Gill Simba |
Director |
限制性股票授予 (RSU) |
25,000 |
$4.79 |
$119.75K |
| 2025-06-17 |
Parshall B Lynne |
Director |
限制性股票授予 (RSU) |
25,000 |
$4.79 |
$119.75K |
| 2025-05-01 |
Gallagher Neil |
Director |
限制性股票授予 (RSU) |
50,000 |
$4.16 |
$208K |
| 2025-05-01 |
Gallagher Neil |
Officer |
未知 |
- |
- |
- |
| 2025-05-01 |
Duty Stuart |
Director |
限制性股票授予 (RSU) |
50,000 |
$4.16 |
$208K |
| 2025-05-01 |
Duty Stuart |
Officer |
未知 |
- |
- |
- |
| 2025-04-25 |
Gottschalk Adrian |
Chief Executive Officer |
赠与（收到） |
300,000 |
- |
- |
